Page 138 - 2021年17期

to improve antitumor efficiency and decrease cardiac to- Control Release，2018，287：78-93.
xicity[J]. AAPS Pharm Sci Tech，2021，22（1）：46. [46] RAJPOOT K. Solid lipid nanoparticles：a promising nano-
[35] WANG X，LIU Y，XU W，et al. Irinotecan and berberine material in drug delivery[J]. Curr Pharm Des，2019，25
co-delivery liposomes showed improved efficacy and re- （37）：3943-3959.
duced intestinal toxicity compared with Onivyde for pan- [47] 马钰，胡静，刘宝瑞，等.纳米给药系统抗恶性肿瘤治疗的
creatic cancer[J]. Drug Deliv Transl Res，2021[2021-04- 研究进展[J].肿瘤基础与临床，2017，30（6）：541-545.
20]. https：//link.springer.com/article/10.1007/s13346-020- [48] LIN S，TSAI S C，LEE C C，et al. Berberine inhibits
00884-4. DOI：10.1007/s13346-020-00884-4. HIF-1alpha expression via enhanced proteolysis[J]. Mol
[36] TUO J，XIE Y，SONG J，et al. Development of a novel Pharmacol，2004，66（3）：612-619．
berberine-mediated mitochondria-targeting nano-platform [49] QI Y，LIU G. Berberine-10-hydroxy camptothecine-loa-
for drug-resistant cancer therapy[J]. J Mater Chem B， ded lipid microsphere for the synergistic treatment of liver
2016，4（42）：6856-6864. cancer by inhibiting topoisomerase and HIF-1α[J]. Drug
[37] 赵耀，杨璨羽，张强，等.肿瘤氧化还原微环境响应型小分 Deliv，2021，28（1）：171-182.
子前药纳米粒的代谢与药效研究进展[J].药学学报， [50] SABRA S，ABDELMONEEM M，ABDELWAKIL M，
2021，56（2）：476-486. et al. Self-assembled nanocarriers based on amphiphilic
[38] LIN C，YANG X，LI H，et al. Self-assembled nanomedi- natural polymers for anti-cancer drug delivery applica-
cine combining a berberine derivative and doxorubicin for tions[J]. Curr Pharm Des，2017，23（35）：5213-5229.
enhanced antitumor and antimetastatic efficacy via mito- [51] KABARY D M，HELMY M W，ELKHODAIRYl K A，
chondrial pathways[J]. Nanoscale，2021，13（13）：6605- et al. Hyaluronate/lactoferrin layer-by-layer-coated lipid
6623. nanocarriers for targeted co-delivery of rapamycin and
[39] CHENG Y，JI Y，TONG J. Triple stimuli-responsive supra- berberine to lung carcinoma[J]. Colloids Surf B Biointer-
molecular nanoassembly with mitochondrial targetability faces，2018，169：183-194.
for chemophotothermal therapy[J]. J Control Release， [52] ZHANG F，JIA Y，ZHENG X，et al. Janus nanocarrier-
2020，327：35-49. based co-delivery of doxorubicin and berberine weakens
[40] ZHENG X，ZHAO Y，JIA Y，et al. Biomimetic co-assem- chemotherapy-exacerbated hepatocellular carcinoma re-
bled nanodrug of doxorubicin and berberine suppresses currence[J]. Acta Biomater，2019，100：352-364.
chemotherapy-exacerbated breast cancer metastasis[J]. [53] LIN H，LIN L，CHOI Y，et al. Development and in-vitro
Biomaterials，2021，271：120716. evaluation of co-loaded berberine chloride and evodia-
[41] KHAN I，JOSHI G，NAKHATE K T，et al. Nano-co-deli- mine ethosomes for treatment of melanoma[J]. Int J
very of berberine and anticancer drug using PLGA Pharm，2020，581：119278.
nanoparticles：exploration of better anticancer activity and [54] QI S S，SUN J H，YU H H，et al. Co-delivery nanoparti-
in vivo kinetics[J]. Pharm Res，2019，36（10）：149. cles of anti-cancer drugs for improving chemotherapy effi-
[42] 谢顺岚，宋金春，杨小青，等.姜黄素聚合物纳米粒的研究 cacy[J]. Drug Deliv，2017，24（1）：1909-1926.
进展[J].医药导报，2015，34（10）：1325-1328. [55] WANG Y，LIU Y，DU X，et al. The anti-cancer mecha-
[43] 寇亮，麻燕琴，罗琨映，等.白蛋白纳米粒给药载体的研究 nisms of berberine：a review[J]. Cancer Manag Res，2020，
进展[J].西北民族大学学报（自然科学版），2017，38（4）： 12：695-702.
9-13. [56] 叶鹏，张文典，杨坦，等.纳米给药系统的抗肿瘤药物联合
[44] ELGOHARY M M，HELMY M W，MORTADA S M， 治疗策略[J].医药导报，2016，35（7）：752-757.
et al. Dual-targeted nano-in-nano albumin carriers en- [57] KEMP J A，SHIM M S，HEO C Y，et al.“Combo”nano-
hance the efficacy of combined chemo/herbal therapy of medicine：co-delivery of multi-modal therapeutics for effi-
lung cancer[J]. Nanomedicine（Lond），2018，13（17）： cient，targeted，and safe cancer therapy[J]. Adv Drug
2221-2224. Deliv Rev，2016，98：3-18.
[45] ABDELMONEEM M A，MAHMOUD M，ZAKY A，et al. （收稿日期：2021-04-25 修回日期：2021-07-04）
Dual-targeted casein micelles as green nanomedicine for （编辑：唐晓莲）
synergistic phytotherapy of hepatocellular carcinoma[J]. J

·2176 · China Pharmacy 2021 Vol. 32 No. 17 中国药房 2021年第32卷第17期